Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium influx in smooth muscle cells is a crucial physiological process mediated by several types of ion channels, most notably voltage-dependent L-type calcium channels (such as Cav1.2). This influx raises intracellular calcium concentrations, initiating contractile processes (excitation-contraction coupling), regulating cell elasticity and adhesion via effects on the actin cytoskeleton and integrin-mediated extracellular matrix interactions, and is fundamental to the maintenance of vascular tone. Dysregulation of calcium influx contributes to diseases including hypertension, atherosclerosis, and vascular calcification. Drugs that block L-type calcium channels are used therapeutically in cardiovascular disease to induce vasodilation and reduce blood pressure, but can have notable safety concerns due to their effects on other tissues.
Inhibition of voltage-dependent L-type calcium channels reduces calcium influx, resulting in smooth muscle relaxation and vasodilation. Blockade of receptor-operated calcium channels may reduce pathological or agonist-mediated contraction.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium influx in smooth muscle cell.